ArticleFrontiers in robotics and AI2025
Optimizing hip exoskeleton assistance pattern based on machine learning and simulation algorithms: a personalized approach to metabolic cost reduction.
Article in Frontiers in robotics and AI, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Embedded Adaptive Admittance Control for a Modular Hip Exoskeleton Using Deep Learning-Based Gait-Phase Estimation.Sensors (Basel, Switzerland) · 2026Article
- EMG-Based Simulation for Optimization of Human-in-the-Loop Control in Simple Robotic Walking Assistance.Journal of sensor and actuator networks · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Introduction: Hip exoskeletons can lower the metabolic cost of walking in many tasks and populations, but their assistance patterns must be tailored to each user. We developed a simulation-based, human-in-the-loop (HIL) optimization framework combining machine learning (ML) and global optimization to personalize hip exoskeleton assistance patterns. Methods: Using data from ten healthy adults, we trained a Gradient Boosting (GB) surrogate model to predict normalized metabolic cost as a function of Peak Magnitude and End Timing of assistive torque. GB achieved the lowest relative absolute error percentage (RAEP) of 0.66%, outperforming Random Forest (RAEP = 0.83%) and Support Vector Regression (RAEP = 0.98%) among nine ML models. We then evaluated seven optimization algorithms, including Covariance Matrix Adaptation Evolution Strategy, Bayesian Optimization, Exploitative Bayesian Optimization, Cross-Entropy, Genetic Algorithm, Gravitational Search Algorithm (GSA), and Particle Swarm Optimization (PSO), to identify optimal assistance profiles. Results: GSA predicted the lowest metabolic cost (-1.06), equivalent to an estimated 53% reduction relative to no exoskeleton assistance, while PSO showed the highest efficiency (AUC = 0.24). Discussion: These simulated predictions, though not empirical measurements, demonstrate the framework's ability to streamline algorithm selection, reduce experimental burden, and accelerate translation of exoskeleton optimization into rehabilitation, occupational, and performance enhancement applications with broader biomechanical and clinical impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.